دورية أكاديمية
Linking ALS mutations to the disruption of the MHC-II pathway.
| العنوان: | Linking ALS mutations to the disruption of the MHC-II pathway. |
|---|---|
| المؤلفون: | Zhang Z; Department of Physiology and Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205., Sun S; Department of Physiology and Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205.; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205. |
| المصدر: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Oct 24; Vol. 120 (43), pp. e2315240120. Date of Electronic Publication: 2023 Oct 11. |
| نوع المنشور: | Journal Article; Comment |
| اللغة: | English |
| بيانات الدورية: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Washington, DC : National Academy of Sciences |
| مواضيع طبية MeSH: | Antigen Presentation* , Histocompatibility Antigens Class II*/immunology, Genes, MHC Class II ; Mutation |
| التعليقات: | Comment on: Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2305756120. (PMID: 37722062) |
| References: | Mol Neurodegener. 2022 Mar 18;17(1):22. (PMID: 35303907) Annu Rev Immunol. 2013;31:443-73. (PMID: 23298205) Proc Natl Acad Sci U S A. 2023 Sep 26;120(39):e2305756120. (PMID: 37722062) J Clin Invest. 2017 Sep 1;127(9):3250-3258. (PMID: 28737506) Nat Neurosci. 2023 Jun;26(6):942-954. (PMID: 37231108) Annu Rev Biochem. 2015;84:355-79. (PMID: 25494299) Acta Neuropathol. 2016 Jul;132(1):145-7. (PMID: 27206760) Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269-81. (PMID: 27033518) Sci Rep. 2018 Jun 8;8(1):8755. (PMID: 29884807) Sci Rep. 2017 Aug 22;7(1):9094. (PMID: 28831083) Nat Neurosci. 2020 May;23(5):615-624. (PMID: 32284607) Mol Cell Neurosci. 2013 Mar;53:34-41. (PMID: 23110760) JAMA Neurol. 2017 Dec 1;74(12):1446-1454. (PMID: 28973548) J Neuroimmune Pharmacol. 2013 Sep;8(4):888-99. (PMID: 23881705) J Neuroimmunol. 2009 May 29;210(1-2):73-9. (PMID: 19307024) Am J Pathol. 1992 Mar;140(3):691-707. (PMID: 1347673) Lancet. 2011 Mar 12;377(9769):942-55. (PMID: 21296405) Science. 2016 Mar 18;351(6279):1324-9. (PMID: 26989253) Nat Neurosci. 2014 Jan;17(1):17-23. (PMID: 24369373) |
| معلومات مُعتمدة: | R01 AG078948 United States AG NIA NIH HHS; RF1 NS113820 United States NS NINDS NIH HHS; RF1 NS127925 United States NS NINDS NIH HHS |
| المشرفين على المادة: | 0 (Histocompatibility Antigens Class II) |
| تواريخ الأحداث: | Date Created: 20231011 Date Completed: 20231101 Latest Revision: 20240412 |
| رمز التحديث: | 20240412 |
| مُعرف محوري في PubMed: | PMC10614208 |
| DOI: | 10.1073/pnas.2315240120 |
| PMID: | 37819987 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1091-6490 |
|---|---|
| DOI: | 10.1073/pnas.2315240120 |